Información del artículo
El Texto completo está disponible en PDF
Bibliografía
[1.]
L. Busquet Duran, K. Naberan Toña, E. Hernández Huet.
Protocolos de asma y enfermedad pulmonar obstructiva crónica (EPOC) en atención primaria.
Fmc Aten Primaria, 1 (1994), pp. 1-40
[2.]
Grupo Español del Estudio del Asma.
Prevalencia de hiperreactividad bronquial y asma en adultos jóvenes de cinco áreas españolas.
Med Clin (Barc), 106 (1996), pp. 761-767
[3.]
I. Aguinaga Ontoso, A. Arnedo Pena, J. Bellido, F. Guillem Grima, M. Morales Suárez Valera.
por el grupo español del estudio ISAAC. Prevalencia de síntomas relacionados con el asma en niños de 13-14 años de 9 poblaciones españolas.
Med Clin (Barc), 112 (1999), pp. 171-175
[4.]
A. Pereira, J.A. Maldonado, M. Sánchez, J. Grávalos, E. Pujol, M. Gómez.
Síntomas respiratorios en población infantil. Estudio ISAAC (International Study of Asthma and Allergies in Childhood).
Arch Bronconeumol, 31 (1995), pp. 383-388
[5.]
V. Sobradillo, M. Miravitlles, C.A. Jiménez, R. Gabriel, J.L. Viejo, J.F. Masa, et al.
Estudio IBERPOC en España: prevalencia de síntomas respiratorios habituales y de limitación crónica al flujo aéreo.
Arch Bronconeumol, 35 (1999), pp. 159-166
[6.]
I. Broder, M.W. Higgins, K.P. Mathews, J.B. Keller.
Epidemiology of asthma and allergic rhinitis in a total community, Tecumseh, Michigan III. Second survey of the community.
J Allergy Clin Immunol, 53 (1974), pp. 127-138
[7.]
C. Fletcher, R. Peto.
The natural history of chronic airflow obstruction.
Bmj, 1 (1977), pp. 1645-1648
[8.]
M. Gillooly, D. Eamb.
Microscopic emphysema in relation to age and smoking habit.
Thorax, 48 (1997), pp. 491-495
[9.]
E.K. Silverman, F.E. Speizer.
Risk factors for the development of chronic obstructive pulmonary disease.
Med Clin North Am, 80 (1996), pp. 501-522
[10.]
R.M. Davis, T.E. Novotny.
The epidemiology of cigarette smoking and its impact on chronic obstructive pulmonary disease.
Am Rev Respir Dis, 140 (1989), pp. S82-S84
[11.]
B.Q. Liu, R. Peto, Z.M. Chen, J. Boreham, Y.P. Wu, J.Y. Li, et al.
Emerging tobacco hazards in China: retrospective proportional mortality study of one million deaths.
Bmj, 317 (1998), pp. 1411-1422
[12.]
S.E. Daniels, S. Bhattachanrya, A. James, N.I. Leaves, A. Young, M.R. Hill, et al.
A genome-wide researche for quantitative trair loci underlying asthma.
Nature, 383 (1996), pp. 247-250
[13.]
S. Romagnani.
Induction of Th1 and Th2 responses: a key role for the natural immune response?.
Immunol Today, 13 (1992), pp. 379-381
[14.]
M. Saetta, A. Di Stefano, G. Turato, F.M. Facchini, L. Corbino, C.E. Mapp, et al.
CD8+ Tlymphocytcs in peripheral airways of smokers with chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 157 (1999), pp. 822-826
[15.]
W. Busse, R. Lemanske.
Advances in immunology.
N Engl J Med, 344 (2001), pp. 350-362
[16.]
P. Barnes.
Chronic Obstuctive Pulmonary Disease.
N Engl J Med, 343 (2000), pp. 269-280
[17.]
A.T. Hill, D. Bayley, R.A.A. Stockley.
The interrelationship of sputum inflammatory markers in patients with chronic bronchitis.
Am J Respir Crit Care Med, 160 (1999), pp. 893-898
[18.]
D. Pratico, S. Basili, M. Vieri, C. Cordova, F. Violi, G.A. Fitzgerald.
Chronic obstructive pulmonary disease is associated with an increase in uri-nary levels of isoprostanc F2a-III, an index of oxidant stress.
Am J Respir Crit Care Med, 158 (1998), pp. 1709-1714
[19.]
S.D. Shapiro.
Elastolytic metalloproteinases produced by human mononuclear phagocytes. Potential roles in destructive lung disease.
Am J Respir Crit Care Med, 150 (1994), pp. S160-S164
[20.]
L.C. Borish, H.S. Nelson, M.J. Lanz, L. Clausen, J.B. Whitemore, J.M. Agosti, et al.
Interleukin-4 receptor in moderate atopic asthma. A phase 17II randomized, placebo-controlled trial.
Am J Respir Crit Care Med, 160 (1999), pp. 1816-1823
[21.]
S.V. Culpitt, W. Maziak, S. Loukidis, J.A. Nightingale, J.L. Matthews, P.J. Barnes.
Effect of high dose inhaled steroid on cells, cytokincs, and pro-teases in induced sputum in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med, 160 (1999), pp. 1635-1639
[22.]
V.M. Keatings, A. Jatakanon, Y.M. Worsdell, P.J. Barnes.
Effects of inhaled and oral glucocorticoids on inflammatory indices in asthma and COPD.
Am J Respir Crit Care Med, 155 (1997), pp. 542-548
[23.]
J.A. Nightingale, D.F. Rogers, K. Fan Chung, P.I. Barnes.
No effect of inhaled budesonide on the response to inhaied ozone in normal subjects.
Am J Respir Crit Care Med, 161 (2000), pp. 479-486
[24.]
P.L. Paggiaro, R. Dahle, I. Bakran, L. Frith, K. Hollingworth, J. Efthimou.
Multicentre randomised-placebo-controlled trial of inhaled fluticasone propionate in patients with chronic obstructive pulmonary disease.
Lancet, 351 (1998), pp. 773-780
[25.]
M. Saetta, A. Di Stefano, P. Maestrelli, G. Turato, M.P. Ruggieri, A. Roggeri, et al.
Airway eosinophilia in chronic bronchitis during exacerbations.
Am J Respir Crit Care Med, 150 (1994), pp. 1646-1652
Copyright © 2003. Elsevier España, S.L.. Todos los derechos reservados
